Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A-kinase anchoring proteins (AKAPs), including the entity sometimes referred to as *A-kinase anchoring protein 19* or *small membrane AKAP (smAKAP)*, comprise a diverse family of scaffold proteins defined primarily by their affinity for the regulatory subunit of protein kinase A (PKA)[1][2][3][4]. AKAPs compartmentalize PKA within the cell, targeting the kinase to specific subcellular domains to orchestrate precise and localized signaling events. This dynamic localization allows PKA and other associated enzymes (e.g., phosphodiesterases and phosphatases) to act efficiently and specifically in response to cAMP and other stimuli, thereby regulating processes including gene transcription, ion channel activity, and cell morphology[1][2][3][4]. While the broader AKAP family (including AKAP18, AKAP79, and AKAP150) has substantial functional and disease relevance, information regarding AKAP19/smAKAP is sparse and inconsistent in recognized scientific databases. Most features and biological roles attributed here are based on the general properties of AKAP family members, as specific roles for AKAP19 remain less well defined in the literature. If further structural or functional information about "AKAP19" becomes available in reference databases, disease contexts, or high-profile studies, these core entries should be revised accordingly. Current ambiguity in the name and lack of druggability or biomarker status indicate this is not a canonical or well-validated therapeutic target[1][2][3][4].
Not applicable for direct drug interaction; generally, AKAPs control the localization and assembly of PKA and other proteins to spatially direct phosphorylation responses in cells[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A-kinase anchoring protein 19 (AKAP19).